Open Journal of Internal Medicine
Vol.04 No.04(2014), Article ID:52645,5 pages

Rheumatoid Arthritis of Man: A Study of 35 Cases in a Senegalese Hospital

Souhaibou Ndongo*, Abdoulaye Pouye, Lionel Ouedraogo, Emeric Azankpan, Ngoné Diack, Thérèse Moreira Diop

Clinique médicale I-H.A.L.D-Dakar, Dakar étoile, Senegal

Email: *

Copyright © 2014 by authors and Scientific Research Publishing Inc.

This work is licensed under the Creative Commons Attribution International License (CC BY).

Received 10 November 2014; revised 1 December 2014; accepted 24 December 2014


Background: Rheumatoid arthritis is predominant in women. In men certain clinical signs can delay diagnosis. Methods: A cross-section study of the epidemio-clinical and immunobiological features of rheumatoid arthritis in a male, black African population was carried out at the Aristide Le Dantec, University hospital of Dakar. Results: we studied 35 male subjects with rheumatoid arthritis. Their mean age was 42 years and the average time between the onset of symptoms to diagnosis was 44 months. In 70% of these patients, at least one joint deformation was present, most frequently an ulnar deviation of the fingers (34.3%). Extra-articular symptoms were dominated by dry eye syndrome (34%) and anemia (17%). Anemia was significantly less frequent in men than in women. The erythrocyte sedimentation rate was accelerated in 51.4% and C reactive proteins were increased in 92% of patients. The rheumatoid factor was positive in all patients and the anti- cyclic Citrullinated Peptide (CCP) antibody was positive in 80% of cases. Conclusion: Male rheumatoid arthritis, relatively less studied, was associated with strongly positive immunological markers and a high rate of joint disorders.


Rheumatoid Arthritis, Male, Senegal

1. Introduction

Rheumatoid arthritis (RA), the most common chronic, inflammatory and rheumatic disease, has genetic and environmental origins [1] . It occurs in all populations predominantly in women [2] -[4] . In men, atypical symptoms, especially in early stages of the disease, can hinder reliable and rapid diagnosis of RA. This study of 35 cases aimed to provide an epidemiological, clinical and immunological description of male RA in a black African population.

2. Patients and Methods

This cross-section study was made on a cohort of 308 patients seen for rheumatoid arthritis in the medical clinic of the university hospital of Aristide Le Dantec in Dakar from 2005 to 2012.

The work focused on male patients satisfying the 1987 diagnostic guidelines of the ACR [5] . Epidemiological and clinical data (duration of the symptoms, description of joint deformations, extra-articular symptoms) as well as biological (blood cells count, erythrocyte sedimentation rate, C-reactive protein) and immunological data (presence of the rheumatoid factor and anti-CCP antibodies) were collected for each patient.

Since quantitative variables did not follow gaussian distributions, they were described with median, 1st quartile and 3rd quartile values. Qualitative variables were defined as the percentage of the population exhibiting each modality of a variable. Quantitative variables were compared using the non-parametric Wilcoxon-Mann- Whitney test. The Chi2 test, if applicable, was used to compare qualitative variables. If not, the exact test of Fisher was used. In all cases the significance level was set at 5%.

3. Results

35 patients, or 11.4% of the cohort studied, were men. The sex ratio was 0.13 and the mean age was 42 years (17 - 80 years).

On average, symptoms were apparent for 44 months (5 - 260 months) before a definitive diagnosis of RA. At least one joint disorder was present in 60% of these patients, most frequently an ulnar deviation of the fingers (34.3%). Joint deformations were bilateral and symmetric, and the same patient could exhibit several different symptoms. Figure 1 summarizes the joint disorders detected in this cohort. Extra-articular symptoms linked to RA are shown in Figure 2. Most frequently, they were dry eye syndrome (34%) or anemia (17%).

The mean erythrocyte sedimentation rate was 25 mm for the first hour (4 - 105 mm). It was increased in 18 of 35, or 51.4%, of these male patients. The average level of C reactive proteins was 24 mg/l (1 - 96 mg/l), an increase over control values in 92% of these patients.

The rheumatoid factor was positive in all patients and anti-CCP antibodies were detected in 80% of cases, at a mean level of 160 IU (2 - 340 UI). Some immunological et biological parameters are summarized in Table 1.

Table 2 compares these different epidemiological, clinical and immunological data according to gender. Table 3 shows the influence of age on the gender balance.

4. Discussion

In this cohort of 35 men and 273 women, a gender ratio of 0.13 confirmed the female predominance of RA [6] [7] . RA is detected at all ages, but most often between 40 and 60 years of age. Over this age range it is about

Figure 1. Frequency of different deformations.

Figure 2. Frequency of extra-articular symptoms.

Table 1. Immunological et biological parameters.

aAnti-CCP antibodies were assessed in only 15 of the 35 patients.

four times more frequent in women than men, but the gender difference is reduced beyond 70 years. The same constation was done with Soubrier and al in France where the sex ratio female/man was about 4 in young people and 2 in elderly [8] . The mean age of male RA patients here was 42 years, comparable to that, 43.5 years, in a Moroccan study from Rkain et al. [9] and somewhat lower than the average age, 51.6 years, of male RA patients in a report from Tunisia [10] .

The average latency from first symptoms to RA diagnosis in this series was 44 months ([5] , p. 260). North African studies report values of 80 - 90 months [10] -[12] , while the mean diagnostic delay for RA in France is given as 6 months [13] . Delayed diagnosis remains a major problem in sub-Saharan Africa. Prognosis deteriorates, especially in functional terms, as joint disorders progress. The diagnostic delay derives from several factors including a sometimes poor knowledge of the syndrome and limited number of medical centers as well as confusion with acute rheumatoid arthritis which remains endemic in sub-Saharan Africa

Joint disorders, present in 60% of our patients, typically concerned the wrists and hands. These regions are frequently (70% - 90%) affected in RA [14] [15] . A relatively mean long diagnostic delay may have contributed to the high proportion (60%) in this cohort. As for differences between men and women of this cohort, the swan neck deformity of the finger was significantly more frequent in men (p = 0.04).

Extra-articular manifestations seem rare in African blacks [16] -[18] , within the limits of interpretation that can give open studies with a limited number of patients.

In our series, in addition to anemia of inflammatory origin (17%), 34% of patients had a secondary sicca syndrome with ocular and oral manifestations. This multifactorial anemia is less frequent in man men than women in our cohort (p = 0.03). Anemia is the most common systemic manifestation in the study of Mody [17] . Rheumatoid nodules, witnessed severe RA were found in only 3% of our patients despite the high seropositivity to rheumatoid factor in our study (100%). Rheumatoid nodules were present in 31.5% of patients in Kenya [19] . However, the diagnosis of rheumatoid nodule should be retained after having excluded infectious causes of skin nodule [20] . The other extra-articular manifestations were rare.

Immunological markers were strongly positive, in agreement with the severity of symptoms in the cohort. Anti-CCP antibodies, a key factor in the prognosis for RA [21] , were positive in 80% of these male patients.

Table 2. Clinical data according to patient gender.

Table 3. Variation of the male-female ratio with age.

5. Conclusion

RA occurs less frequently and is less studied in men than in women. In this series of young, adult African males with RA, immunological markers were strongly expressed. Diverse deformations of the hand were frequent, possibly due to long latencies to diagnosis.


Our work has limitations related to important diagnostic delay, which could introduce a bias in the interpretation of the severity of RA. Indeed, the average length of evolution of symptoms before diagnosis was 44 months. Purely hospital setting does not allow extrapolating the results of this study in the general population.


  1. Morel, J., Miossec, P. and Combe, B. (2004) Immunopathologie de la polyarthrite rhumatoïde. EMC Rhumatologie Orthopédie, 1, 218-230.
  2. Sokka, T., Abelson, B. and Pincus, T. (2008) Mortality in Rheumatoid Arthritis: 2008 Update. Clinical and Experimental Rheumatology, 26, S35-S61.
  3. Guillemin, F., Saraux, A., Guggenbuhl, P., Roux, C.H., Fardellone, P. and Le Bihan, E. (2005) Prevalence of Rheumatoid Arthritis in France: 2001. Annals of the Rheumatic Diseases, 64, 1427-1430.
  4. Kahn, M.F. (2004) Peut-on estimer l’incidence et la prévalence de la polyarthrite rhumatoïde en France ainsi que leur évolution? Revue du Rhumatisme, 71, 180-182.
  5. Arnett, F.C., Edworthy, S.M., Bloch, D.A., McShane, D.J., Fries, J.F., Cooper, N.S., et al. (1988) The American Rheu- matism Association 1987 Revised Criteria for the Classification of Rheumatoid Arthritis. Arthritis & Rheumatology, 31, 315-324.
  6. Roux, H. (2002) Polyarthrite rhumatoïde en Afrique subsaharienne. Revue du Rhumatisme, 69, 797-800.
  7. Widdifield, J., Paterson, J.M., Bernatsky, S., Tu, K., Tomlinson, G., Kuriya, B., et al. (2014) The Epidemiology of Rheumatoid Arthritis in Ontario, Canada. Arthritis & Rheumatology, 66, 786-793.
  8. Soubrier, M., Mathieu, S., Payet, S., Dubost, J.-J. and Ristori, J.-M. (2010) La polyarthrite rhumatoïde du sujet âgé. Revue du Rhumatisme, 77, 326-332.
  9. Rkain, H., Allali, F., Jroundi, I. and Najia, H.-H. (2006) Retentissement socioéconomique de la polyarthrite rhumatoïde (PR) au Maroc. Revue du Rhumatisme, 73, 462-468.
  10. Frikha, F., Elloumi, H., Marzouk, S., Kaddour, N., Jallouli, M., Kechaou, M., et al. (2007) Polyarthrite rhumatoïde masculine: A propos de 46 cas. Revue du Rhumatisme, 74, 1048 p.
  11. Pillon, F. and Michiels, Y. (2013) Epidémiologie et physiopathologie de la polyarthrite rhumatoïde. Actualités Phar- maceutiques, 52, 1-2.
  12. Slimani, S., Abbas, A., Ammar, A.B., Kebaili, D., Ali, E.H., Rahal, F., et al. (2014) Characteristics of Rheumatoid Arthritis in Algeria: A Multicenter Study. Rheumatology International, 34, 1235-1239.
  13. Muis Pistor, O., Fantino, B., Piot-Fantino, F., Garret, C., Trape, G. and Tebiba, J. (2013) Diagnostic et prise en charge thérapeutique de la polyarthrite rhumatoïde en Rhône-Alpes: Une enquête “vraie vie” en 2010. Revue du Rhumatisme, 80, 130-135.
  14. Chammas, M. (2005) Le poignet rhumatoïde. Chirurgie de la Main, 245, 275-298.
  15. Macholds, K.P., Stamm, T.A., Eberl, G.J., Nell, V.K., Dunky, A., Uffmann, M., et al. (2002) Very Recent Onset Arthritis. Clinical, Laboratory and Radiological Findings during the First Year of Disease. The Journal of Rheumatology, 29, 2278-2287.
  16. Sankalé, M., Sow, A.M., Diop, B., Touré, Y.I. and Ruscher, H. (1977) General Features of Rheumatoid Arthritis in Black Africans. Concours Médical, 99, 1103-1112. (In French)
  17. Feldman, D.E., Bernatsky, S., Haggerty, J., et al. (2007) Delay in Consultation with Specialists for Persons with Suspected New-Onset Rheumatoid Arthritis: A Population-Based Study. Arthritis Care & Research, 57, 1419-1425.
  18. Dieye, A., Diallo, S., Diatta, M., et al. (1997) Identification of HLA-DR Alleles for Susceptibility to Rheumatoid Polyarthritis in Senegal. Dakar Médical, 42, 111-113.
  19. Mody, G.M. and Meyers, O.L. (1989) Rheumatoid Arthritis in Blacks in South Africa. Annals of the Rheumatic Diseases, 48, 69-72.
  20. Greenwood, B.M. (1969) Polyarthritis in Western Nigeria. I. Rheumatoid Arthritis. Annals of the Rheumatic Diseases, 28, 488-496.
  21. Omar, A., Abo-Elyoun, I., Hussein, H., Nabih, M., Atwa, H., Gad, S., et al. (2013) Anti-Cyclic Citrullinated Peptide (Anti-CCP) Antibody in Juvenile Idiopathic Arthritis (JIA): Correlations with Disease Activity and Severity of Joint Damage (a Multicenter Trial). Joint, Bone, Spine, 80, 38-43.


*Corresponding author.